You may contribute to helping speed a cure for Parkinson's disease through a gift in your will or other estate plans. Such gifts are easy to establish and may reduce the estate taxes that may be levied against your property. This charitable deduction can greatly reduce the cost of making a bequest. Although legal consultation is always advisable before designing any type of will provision, you should know that a bequest may be simply stated as follows:
"I give and bequeath to The Michael J. Fox Foundation for Parkinson's Research _________% of my total estate (or $___________)."
If the Foundation determines at any time that a bequest cannot be used as it was originally intended, the Foundation will apply the proceeds to a purpose that most closely resembles the donor's intention. Providing such a provision in your will creates an unrestricted bequest, which assures that your gift, will be used where it is most needed.
Patients first
We strive to make progress in Parkinson's disease in the following key areas by evaluating risk, opportunities and challenges through a patient-focused lens, including:
Treatments that can slow, stop or reverse disease
Better treatments for currently unaddressed or under-addressed symptoms
Treatments to address or avoid the debilitating side effects of current PD drugs
Patients first
We strive to make progress in Parkinson's disease in the following key areas by evaluating risk, opportunities and challenges through a patient-focused lens, including:
Treatments that can slow, stop or reverse disease
Better treatments for currently unaddressed or under-addressed symptoms
Treatments to address or avoid the debilitating side effects of current PD drugs
Our model is different
Our Foundation is a trusted strategic leader and partner to researchers, patients, thought leaders and philanthropists. With an unbiased expert perspective and a global network of contacts, our wide-ranging view of the field lets us collaborate to solve complex problems that require different talents and target resources where they are needed most — to pay off for patients faster.
It is accepted practice among private disease research funders that the most important decisions — how to allocate donor-raised dollars — are made by external scientific advisors and boards. We bucked this model from day one in favor of building an in-house team of formally trained PhDs and business-trained project managers.
We’re on a mission to meet every person with Parkinson’s online or face to face. We're committed to connecting patients and families to the robust nationwide PD community. By participating in clinical trials, advocating for Parkinson's policy or engaging in our community and Team Fox events, they are helping us carry new therapies over the goal line.
Our model is different
Our Foundation is a trusted strategic leader and partner to researchers, patients, thought leaders and philanthropists. With an unbiased expert perspective and a global network of contacts, our wide-ranging view of the field lets us collaborate to solve complex problems that require different talents and target resources where they are needed most — to pay off for patients faster.
It is accepted practice among private disease research funders that the most important decisions — how to allocate donor-raised dollars — are made by external scientific advisors and boards. We bucked this model from day one in favor of building an in-house team of formally trained PhDs and business-trained project managers.
We’re on a mission to meet every person with Parkinson’s online or face to face. We're committed to connecting patients and families to the robust nationwide PD community. By participating in clinical trials, advocating for Parkinson's policy or engaging in our community and Team Fox events, they are helping us carry new therapies over the goal line.